We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$97.8M
2
AAPL icon
Apple
AAPL
+$7.77M
3
COST icon
Costco
COST
+$6.63M
4
FRO icon
Frontline
FRO
+$5.7M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$5.47M

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VSTS icon
1426
Vestis
VSTS
$1.88B
$191K 0.01%
+12,533
New +$189K
AVNW icon
1427
Aviat Networks
AVNW
$273M
$190K 0.01%
10,465
-9,361
-47% -$172K
OTLK icon
1428
Outlook Therapeutics
OTLK
$191M
$190K 0.01%
+100,319
New +$413K
STIM icon
1429
Neuronetics
STIM
$166M
$189K 0.01%
117,142
+38,500
+49% +$40K
NVCT icon
1430
Nuvectis Pharma
NVCT
$617M
$188K 0.01%
34,751
-15,378
-31% -$96.3K
TARA icon
1431
Protara Therapeutics
TARA
$232M
$188K 0.01%
+35,547
New +$115K
SPRY icon
1432
ARS Pharmaceuticals
SPRY
$612M
$185K 0.01%
17,574
-81,326
-82% -$1.14M
WRAP icon
1433
Wrap Technologies
WRAP
$104M
$185K 0.01%
87,460
+57,804
+195% +$95.2K
CLB icon
1434
Core Laboratories
CLB
$521M
$182K 0.01%
10,542
-12,858
-55% -$248K
FIP icon
1435
FTAI Infrastructure
FIP
$505M
$182K 0.01%
25,070
-108,663
-81% -$931K
GGB icon
1436
Gerdau
GGB
$9.7B
$182K 0.01%
+63,283
New +$209K
NOAH
1437
Noah Holdings
NOAH
$603M
$181K 0.01%
+15,447
New +$191K
PACS icon
1438
PACS Group
PACS
$7.67B
$181K 0.01%
13,779
-16,963
-55% -$435K
YMM icon
1439
Full Truck Alliance
YMM
$9.99B
$178K 0.01%
16,446
-29,728
-64% -$290K
ENTA icon
1440
Enanta Pharmaceuticals
ENTA
$400M
$177K 0.01%
+30,726
New +$295K
KROS icon
1441
Keros Therapeutics
KROS
$221M
$177K 0.01%
+11,158
New +$580K
CERT icon
1442
Certara
CERT
$1.25B
$175K 0.01%
+16,414
New +$178K
LONA
1443
LeonaBio Inc
LONA
$72.1M
$174K 0.01%
29,656
-10,055
-25% -$56.7K
CCU icon
1444
Compañía de Cervecerías Unidas
CCU
$2.21B
$174K 0.01%
+15,350
New +$173K
CURV icon
1445
Torrid Holdings
CURV
$260M
$174K 0.01%
33,342
-74,892
-69% -$301K
DSL
1446
DoubleLine Income Solutions Fund
DSL
$1.24B
$174K 0.01%
+13,871
New +$176K
ARDT
1447
Ardent Health
ARDT
$1.66B
$172K 0.01%
+10,065
New +$174K
CFB
1448
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$172K 0.01%
+11,347
New +$188K
SGHT icon
1449
Sight Sciences
SGHT
$412M
$171K 0.01%
46,967
+25,453
+118% +$116K
TDUP icon
1450
ThredUp
TDUP
$422M
$171K 0.01%
123,296
-32,258
-21% -$36.2K
56 57
58
59 60

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.